Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Ozempic
Recent news which mentions Ozempic
< Previous
1
2
3
4
5
6
Next >
Denmark Mulls Changes To Diabetes Drug Subsidies: A Closer Look At Weight Loss Drug Debate
August 23, 2023
Tickers
NVO
Tags
NVO
General
News
From
Benzinga
Fake Ozempic Injections Circulate Social Media Amid Global Shortage: 'Felt Like I Was Going To Die'
August 21, 2023
Tags
Ozempic
Benzinga
Biotech
From
Benzinga
Kim Kardashian Faces Ozempic Accusations Over Dramatic Weight Loss
August 19, 2023
Tags
Weight Loss
Benzinga
Ozempic
From
Benzinga
Famed Weight Loss Drugs - Medications Far Pricier In US Than Other Developed Countries
August 18, 2023
Tickers
LLY
NVO
Tags
Market News
Health Care
wegovy
From
Benzinga
Ozempic Competitor Wegovy Could Prevent 1.5M Heart Attacks And Strokes Over 10 Years, Study Reveals
August 16, 2023
Tickers
NVO
Tags
wegovy
Novo Nordisk
Market News
From
Benzinga
Former Playboy Model Jenna Jameson Denies Using Weight Loss Drug Ozempic: 'Just Minding My Health'
August 15, 2023
Tags
Playboy
Benzinga
Ozempic
From
Benzinga
Ozempic Shifts Perception Of Obesity From Being About Willpower To Biology: WSJ
August 15, 2023
Tags
Market News
Ozempic
Benzinga
From
Benzinga
Tracy Morgan Credits 'Miracle' Weight Loss Drug Ozempic For Shedding Pounds: 'I Ain't Letting It Go!'
August 15, 2023
Tags
Tracy Morgan
Entertainment
General
From
Benzinga
Weight-Loss Drugs Ozempic, Wegovy Pose Life-Threatening Risks For Surgery And Anesthesia Patients: Expert Warns
August 13, 2023
Tags
Market News
weightloss
Media
From
Benzinga
Jeff Lewis' Humorous 'Lesbian On Ozempic' Comment Results In Kyle Richards Ignoring Messages, 'Bravo' Star Says
August 10, 2023
Tags
Benzinga
Ozempic
Jeff Lewis
From
Benzinga
Obesity Drug Wegovy Sales Jump 365% In H1 As Novo Nordisk Reports Solid Results, Raises FY23 Guidance
August 10, 2023
Tickers
LLY
NVO
Tags
LLY
Top Stories
News
From
Benzinga
'Welcome To Crappie Lake' Stars Luann De Lesseps, Sonja Morgan Refute Ozempic Use: 'Are You Trying To Give Us A Hint?'
August 09, 2023
Tags
Weight Loss
General
Entertainment
From
Benzinga
Ozempic Linked To Severe 'Roller Coaster Ride' Side Effects In Diabetic Patients
August 09, 2023
Tags
Type/ 2 diabetes
Biotech
Ozempic
From
Benzinga
Wegovy, Ozempic Could Save 139,400 Lives In US Each Year; Novo Nordisk Heart Attack Research Reveals New Benefits
August 08, 2023
Tickers
LLY
NVO
Tags
NVO
News
General
From
Benzinga
'Miracle' Weightloss Drugs Ozempic And Mounjaro Face Lawsuit Over Alleged Gastroparesis Side Effect
August 04, 2023
Tickers
LLY
NVO
Tags
Ozempic
Benzinga
lawsuit
From
Benzinga
Plastic Surgeon Hails 'Miracle' Weightloss Drug Ozempic, Says 'They're Better' Than Botox
August 03, 2023
Tags
Ozempic
Benzinga
healthcare
From
Benzinga
Sharon Osbourne Reveals Unpleasant Experience With Weight Loss Drug Ozempic: 'First Week Was F***ing S**t'
August 03, 2023
Tags
Ozempic
Benzinga
Weight Loss
From
Benzinga
'Miracle' Weightloss Drugs Ozempic, Wegovy Can 'Pull The Trigger' For Eating Disorders
August 02, 2023
Tags
News
wegovy
General
From
Benzinga
Keke Palmer Criticizes 'Miracle' Weightloss Drug Ozempic Users: 'Folks With Diabetes Ain't Able To Get It'
August 02, 2023
Tags
Benzinga
Ozempic
News
From
Benzinga
Elon Musk, Mark Zuckerberg, Jeff Bezos Shine Spotlight On Body Image Issues, Ozempic Craze Intensifies
August 02, 2023
Tags
News
Weight/based discrimination
General
From
Benzinga
'Real Housewives' Star Jennifer Pedranti Backs Emily Simpson For Using 'Miracle' Weightloss Drug Ozempic, 'People Are Very Judgmental'
July 31, 2023
Tags
General
News
weightloss
From
Benzinga
UK Pharmacies Grapple With Shortage Of 'Miracle' Weight Loss Drug Ozempic — Lives Of Diabetic Patients At Risk
July 31, 2023
Tags
News
General
United Kingdom
From
Benzinga
Emily Simpson Used 'Miracle' Drug Ozempic, Popularized By Kim Kardashian And Elon Musk, To Kickstart Weight-Loss Journey
July 27, 2023
Tags
Health Care
Media
Diabetes
From
Benzinga
Expert Warns 'Miracle' Weight Loss Drug Ozempic Might Require Lifelong Use: 'Are You Prepared...?'
July 27, 2023
Tags
Ozempic
Benzinga
General
From
Benzinga
Teresa Giudice Under Fire From Fans Over Ozempic And Photoshop Claims: 'Please Be Real'
July 26, 2023
Tags
Biotech
Benzinga
Ozempic
From
Benzinga
'Stop Making People Feel Bad': Plastic Surgeon Lambasts Ozempic 'Shaming'
July 25, 2023
Tags
Weight Loss
Benzinga
Ozempic
From
Benzinga
Novo Nordisk's Ozempic And Wegovy Under Scrutiny Amid Reports Of 'Stomach Paralysis'
July 25, 2023
Tickers
NVO
Tags
Diabetes
NVO
General
From
Benzinga
Ozempic Alternatives: These Two Drugs Show Promise In Affordability And Effectiveness For Weight Loss
July 24, 2023
Tags
General
News
Weight Loss
From
Benzinga
Tamra Judge Criticizes Celebrities For Taking Kim Kardashian Popularized Weight Loss Drug Ozempic: 'I Don't Take Shortcuts'
July 21, 2023
Tags
News
Entertainment
The Real Housewives
From
Benzinga
TikTok Cracks Down On Health Influencers Amid Growing Popularity Of 'Miracle' Weight Loss Drug Ozempic
July 19, 2023
Tags
influencers
health care
Global
From
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.